Zhongxing BioTech released its performance for the first three quarters, with a net profit attributable to the parent company of 204 million yuan, a year-on-year increase of 130.51%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Zhongxing BioTech released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 1.475 billion yuan, a year-on-year increase of 4.16%. The net profit attributable to shareholders of the listed company was 204 million yuan, a year-on-year increase of 130.51%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 184 million yuan, a year-on-year increase of 181.09%
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments